Axsome Therapeutics’ AXS-05 challenges current standard of care as promising non-antipsychotic for Alzheimer’s agitation: GlobalData Read more
Shilpa Pharma Lifesciences’ Raichur API facility clears second consecutive FDA inspection with no observations Read more
Logistics4Pharma expands customs services with transit document management and bonded storage near Frankfurt airport Read more
FOPE and PharmaState Academy conduct session on sterile drug manufacturing under Revised Schedule M Read more
Large pharma drug licensing from China reaches record high at 28 per cent in 2024, reveals GlobalData Read more